Journal overview and metrics: Therapeutic Advances in Infectious Disease: Sage Journals

Description

Aims and scope

Metrics

Abstracting and indexing

Journal Highlights

Launched in 2013
Gold open access journal – all articles are made freely available online immediately upon publication
Rigorous peer review
Listed in PubMed and indexed in Web of Science, Emerging Sources Citation Index (ESCI) and Scopus

Therapeutic Advances in Infectious Disease (TAI) is a peer-reviewed open access journal, which focuses on the highest quality research, reviews and scholarly comment on pioneering efforts and innovative studies across all areas of infectious disease. This includes articles examining the social determinants of health. The journal is aimed at an international audience of clinicians, researchers and students/trainees in infectious disease, providing an online forum for publishing the highest quality articles in this field.

The journal is a member of the Committee on Publication Ethics (COPE)

Diversity, Equity and Inclusion Statement

Therapeutic Advances in Infectious Disease (TAI) promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the infectious disease community.

Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.

We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.

We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.

Submission information

Submit your manuscript today at http://mc.manuscriptcentral.com/taid.

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.

The journal changed its publication mode from subscription to open access in 2019.

Open access article processing charge (APC) information

Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licence. The standard APC is $3000 USD. The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.

Meet the Editorial Team
Click here to meet the Editorial Team of Therapeutic Advances in Infectious Disease.

Contact

Please direct any enquiries to TAInfectiousDisease@sagepub.co.uk.